ArticleMolecular therapy. Advances2026

CSF GAG non-reducing ends in MPS IH after peripheral and brain-penetrating therapies: A model comparing IV non-targeted ERT and HCT.

Troy C Lund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.